Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis
A research team from Spain, which was led by Carmen Gallardo, has prepared a Cochrane systematic review that explores the efficacy, safety, and adherence to fixed-dose combinations (FDCs) of drugs versus single-drug formulations to treat people who are newly diagnosed with tuberculosis (TB).